valsartan has been researched along with Retinal Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Binger, KJ; Campbell, DJ; Cooper, ME; Fletcher, EL; Hatzopoulos, KM; Heine, R; Miller, AG; Tan, G; Wilkinson-Berka, JL | 1 |
Albini, TA; Foroozan, R; Lakhanpal, RR; Lopez, GA; McPherson, AR | 1 |
2 other study(ies) available for valsartan and Retinal Diseases
Article | Year |
---|---|
RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina.
Topics: Animals; Animals, Newborn; Cell Survival; Chymosin; Disease Models, Animal; Enzyme Precursors; Neovascularization, Physiologic; Neuroglia; Neurons; Oligopeptides; Probability; Prorenin Receptor; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Reference Values; Retina; Retinal Diseases; Retinal Vessels; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2010 |
Retinopathy and choroidopathy as the initial signs of hypertensive brainstem encephalopathy.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Brain Stem; Choroid Diseases; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Hypertensive Encephalopathy; Magnetic Resonance Imaging; Metoprolol; Middle Aged; Retinal Diseases; Tetrazoles; Valine; Valsartan | 2006 |